WRM
LGND icon

Westport Resources Management’s Ligand Pharmaceuticals LGND Stock Holding History

Westport Resources Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-641
Closed -$25K – 1031
2014
Q2 		$25K Sell
641
-2,405
-79% -$97.6K 0.01% 681
2014
Q1 		$128K Buy
3,046
+641
+27% +$26.7K 0.04% 377
2013
Q4 		$79K Buy
+2,405
New +$78.4K 0.02% 461

Other funds holding LGND

RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westport Resources Management's LGND Position: Q3 2014 in Review

Westport Resources Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2014, closing a stake of 641 shares — an estimated $25K sold.

Westport Resources Management first reported a position in LGND in Q4 2013 and held it in 3 quarters. The position peaked at $128K in Q1 2014. 174 funds tracked by Wall St. Rank hold LGND as of Q3 2014.

  • Westport Resources Management reported no remaining Ligand Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Westport Resources Management sold 641 Ligand Pharmaceuticals shares in Q3 2014, an estimated $25K.
  • Westport Resources Management first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 3 quarters.
  • Westport Resources Management's Ligand Pharmaceuticals position peaked at $128K in Q1 2014.
  • 174 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2014.

Based on Westport Resources Management's 13F filing for Q3 2014, filed 29 Oct 2014.